Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design

被引：0
作者：
Peter W. Nickerson
Georg A. Böhmig
Steve Chadban
Deepali Kumar
Roslyn B. Mannon
Teun van Gelder
James C. Lee
Scott Adler
Edward Chong
Arjang Djamali
机构：
[1] University of Manitoba,
[2] Medical University of Vienna,undefined
[3] University of Sydney,undefined
[4] University of Toronto,undefined
[5] University of Nebraska Medical Center,undefined
[6] Leiden University Medical Center,undefined
[7] CSL Behring,undefined
[8] University of Wisconsin,undefined
来源：
Trials | / 23卷
关键词：
Chronic active antibody-mediated rejection; Clazakizumab; Estimated glomerular filtration rate; Kidney transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 231 条
[51]  
Gray D(undefined)undefined undefined undefined undefined-undefined
[52]  
Hughes J(undefined)undefined undefined undefined undefined-undefined
[53]  
Wu G(undefined)undefined undefined undefined undefined-undefined
[54]  
Chai N(undefined)undefined undefined undefined undefined-undefined
[55]  
Kim I(undefined)undefined undefined undefined undefined-undefined
[56]  
Klein AS(undefined)undefined undefined undefined undefined-undefined
[57]  
Jordan SC(undefined)undefined undefined undefined undefined-undefined
[58]  
Casiraghi F(undefined)undefined undefined undefined undefined-undefined
[59]  
Ruggenenti P(undefined)undefined undefined undefined undefined-undefined
[60]  
Noris M(undefined)undefined undefined undefined undefined-undefined
12345678910